Neurodevelopment in Schizophrenia. Matcheri S. Keshavan,
James L. Kennedy, and Robin M. Murray (Eds.). (2004). Cambridge, UK:
Cambridge University Press. 506 pp., $150.00.
Liberman and Corrigan stated in a 1992
editorial in the Journal of Neuropsychiatry and Clinical
Neuroscience, “The question is no longer whether schizophrenia
is a brain disease but rather what type of disease underlies its
characteristics, symptoms, signs, and associated disabilities” (p.
119). It has been 13 years since Liberman and Corrigan wrote this
editorial, and there has been a steady increase in the interest in
schizophrenia among neuropsychologists as judged by the quality and
quantity of papers presented at professional meetings and published in
neuropsychology journals. In the April 2005
issue of The American Psychologist, Heinrichs asserted that
effect sizes derived from neuropsychological tests of memory, attention,
language, and reasoning are twice as large as those obtained from
neuroimaging studies on individuals with schizophrenia. He concludes that
“schizophrenia is a complex biobehavioral disorder that manifests
itself primarily in cognition.” (p. 229). However, large effect
sizes on neuropsychological tests are considerably
“downstream” from the genesis of the disorder, which is widely
believed to be neurodevelopmental in nature, rather than
neurodegenerative. What is the neuropathological mechanism that underlies
this complex cognitive disorder? This book, Neurodevelopment in
Schizophrenia, is an edited volume that brings together basic and
clinical neuroscientists who are trying to answer this question—what
is the disease mechanism underlying schizophrenia that derails normal
neurodevelopment?